Abstract
Purpose
High prevalence mental disorders including depression, anxiety and substance use disorders are associated with high economic and disease burden. However, there is little information regarding the health state utility values of such disorders according to their clinical severity using comparable instruments across all disorders. This study reports utility values for high prevalence mental disorders using data from the 2007 Australian National Survey of Mental Health and Wellbeing (NSMHWB).
Methods
Utility values were derived from the AQoL-4D and analysed by disorder classification (affective only (AD), anxiety-related only (ANX), substance use only (SUB) plus four comorbidity groups), severity level (mild, moderate, severe), symptom recency (reported in the past 30 days), and comorbidity (combination of disorders). The adjusted Wald test was applied to detect statistically significant differences of weighted means and the magnitude of difference between groups was presented as a modified Cohen’s d.
Results
In total, 1526 individuals met criteria for a 12-month mental disorder. The mean utility value was 0.67 (SD = 0.27), with lower utility values associated with higher severity levels and some comorbidities. Utility values for AD, ANX and SUB were 0.64 (SD = 0.25), 0.71 (SD = 0.25) and 0.81 (SD = 0.19), respectively. No differences in utility values were observed between disorders within disorder groups. Utility values were significantly lower among people with recent symptoms (within past 30 days) than those without; when examined by diagnostic group, this pattern held for people with SUB, but not for people with ANX or AD.
Conclusions
Health state utility values of people with high prevalence mental disorders differ significantly by severity level, number of mental health comorbidities and the recency of symptoms, which provide new insights on the burden associated with high prevalence mental disorders in Australia. The derived utility values can be used to populate future economic models.
Similar content being viewed by others
References
Brazier, J., Ratcliffe, J., Salomon, J. A., & Tsuchiya, A. (2017). Measuring and valuing health benefits fo economic evaluation. Oxford: Oxford University Press.
NICE. (2013). Guide to the methods of technology appraisal 2013. London: NICE.
Pharmaceutical Benefits Advisory Committee. (2008). Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (Version 4.3). Canberra, ACT: Australian Governmnet - Department of Health and Ageing.
Hawthorne, G., Richardson, J., & Osborne, R. (1999). The assessment of quality of life (AQoL) instrument: A psychometric measure of health-related quality of life. Quality of Life Research, 8, 209–224.
Richardson, J. R., Peacock, S. J., Hawthorne, G., Iezzi, A., Elsworth, G., & Day, N. A. (2012). Construction of the descriptive system for the Assessment of Quality of Life AQoL-6D utility instrument. Health and Quality of Life Outcomes, 10, 38.
Richardson, J., Iezzi, A., Khan, M. A., & Maxwell, A. (2014). Validity and reliability of the assessment of quality of life (AQoL)-8D multi-attribute utility instrument. Patient, 7, 85–96.
Brooks, R., Rabin, R., & de Charro, F. E. (2003). The measurement and valuation of health status using EQ-5D: A European perspective. Dordrecht: Kluwer Academic Publisher.
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20, 1727–1736.
Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21, 271–292.
Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42, 851–859.
Whitehurst, D. G., Norman, R., Brazier, J. E., & Viney, R. (2014). Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises. Value in Health, 17, 570–577.
Mohiuddin, S., & Payne, K. (2014). Utility values for adults with unipolar depression: Systematic review and meta-analysis. Medical Decision Making, 34, 666–685.
Revicki, D. A., Brandenburg, N., Matza, L., Hornbrook, M. C., & Feeny, D. (2008). Health-related quality of life and utilities in primary-care patients with generalized anxiety disorder. Quality of Life Research, 17, 1285–1294.
Revicki, D. A., Hanlon, J., Martin, S., Gyulai, L., Nassir Ghaemi, S., Lynch, F., et al. (2005). Patient-based utilities for bipolar disorder-related health states. Journal of Affective Disorders, 87, 203–210.
Revicki, D. A., & Wood, M. (1998). Patient-assigned health state utilities for depression-related outcomes: Differences by depression severity and antidepressant medications. Journal of Affective Disorders, 48, 25–36.
Hawthorne, G., Korn, S., & Richardson, J. (2013). Population norms for the AQoL derived from the 2007 Australian National Survey of Mental Health and Wellbeing. Australian and New Zealand Journal of Public Health, 37, 7–16.
Slade, T., Johnston, A., Oakley Browne, M. A., Andrews, G., & Whiteford, H. (2007). National Survey of Mental Health and Wellbeing: Methods and key findings. Australian and New Zealand Journal of Psychiatry, 43, 594–605.
Australian Bureau of Statistics. National Survey of Mental Health and Wellbeing: Users’ guide, 2007. Retrieved March 28, 2018 from http://www.abs.gov.au/ausstats/abs@.nsf/Latestproducts/4327.0Main%20Features12007.
Slade, J., Teeson, W., & Burgess, P. (2009). The mental health of Australians 2: Report on the 2007 National Survey of Mental Health and Wellbeing. Canberra: Department of Health.
Richardson, J., Hawthorne, G., Day, N. A., Osborne, R., & McNeil, H. (1998). Difficulty with life and death: Methodological issues and results from the utility scaling of the assessment of quality of life (AQoL) instrument. Working paper 70. Melbourne, VIC: The Centre for Health Program Evaluation (CHPE), Monash University.
Kessler, R. C., Barker, P. R., Colpe, L. J., Epstein, J. F., Gfroerer, J. C., Hiripi, E., et al. (2003). Screening for serious mental illness in the general population. Archives of General Psychiatry, 60, 184–189.
Rehm, J., Üstün, T. B., Saxena, S., Nelson, C. B., Chatterji, S., Ivis, F., et al. (1999). On the development and psychometric testing of the WHO screening instrument to assess disablement in the general population. International Journal of Methods in Psychiatric Research, 8, 110–122.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Erlbaum.
Ferguson, C. J.. (2009). An effect size primer: A guide for clinicians and researchers. Professional Psychology, Research and Practice, 40, 532.
StataCorp. (2013). Stata statistical software: Release 13. College Station, TX: StataCorp LP.
Hawthorne, G., & Osborne, R. (2005). Population norms and meaningful differences for the assessment of quality of life (AQoL) measure. Australian and New Zealand Journal of Psychiatry, 29, 136–142.
Roberts, J., Lenton, P., Keetharuth, A. D., & Brazier, J. (2014). Quality of life impact of mental health conditions in England: Results from the adult psychiatric morbidity surveys. Health and Quality of Life Outcomes, 12, 6.
Lamers, L. M., Bouwmans, C. A., van Straten, A., Donker, M. C., & Hakkaart, L. (2006). Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Economics, 15, 1229–1236.
Peasgood, T., & Brazier, J. (2015). Is meta-analysis for utility values appropriate given the potential impact different elicitation methods have on values? Pharmacoeconomics, 33, 1101–1105.
Sonntag, M., Konig, H. H., & Konnopka, A. (2013). The estimation of utility weights in cost-utility analysis for mental disorders: A systematic review. Pharmacoeconomics, 31, 1131–1154.
Richardson, J., Iezzi, A., & Khan, M. A. (2015). Why do multi-attribute utility instruments produce different utilities: The relative importance of the descriptive systems, scale and ‘micro-utility’ effects. Quality of Life Research, 24, 2045–2053.
Richardson, J., Iezzi, A., Khan, M. A., Chen, G., & Maxwell, A. (2015). Measuring the sensitivity and construct validity of 6 utility instruments in 7 disease areas. Medical Decision Making, 36, 147–159.
Mihalopoulos, C., Chen, G., Iezzi, A., Khan, M., & Richardson, J. (2014). Assessing outcomes for cost-utility analysis in depression: Comparison of five multi-attribute utility instruments with two depression-specific outcome measures. British Journal of Psychiatry, 205, 390–397.
Herrman, H., Hawthorne, G., & Thomas, R. (2002). Quality of life assessment in people living with psychosis. Social Psychiatry and Psychiatric Epidemiology, 37, 510–518.
Hawthorne, G., Richardson, J., & Day, N. A. (2001). A comparison of the assessment of quality of life (AQoL) with four other generic utility instruments. Annals of Medicine, 33, 358–370.
Reavley, N. J., & Jorm, A. F. (2012). Public recognition of mental disorders and beliefs about treatment: Changes in Australia over 16 years. The British Journal of Psychiatry, 200, 419–425.
Pilkington, P. D., Reavley, N. J., & Jorm, A. F. (2013). The Australian public’s beliefs about the causes of depression: Associated factors and changes over 16 years. Journal of Affective Disorders, 150, 356–362.
Reavley, N. J., & Jorm, A. F. (2012). Stigmatising attitudes towards people with mental disorders: Changes in Australia over 8 years. Psychiatry Research, 197, 302–306.
Acknowledgements
We thank the Australian Bureau of Statistics for access to the 2007 NSMHWB. The 2007 NSMHWB was funded by the Australian Government Department of Health and Ageing, and conducted by the Australian Bureau of Statistics.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
This study was conducted without financial support and the authors report no conflict of interest.
Rights and permissions
About this article
Cite this article
Mihalopoulos, C., Engel, L., Le, L.KD. et al. Health state utility values of high prevalence mental disorders in Australia: results from the National Survey of Mental Health and Wellbeing. Qual Life Res 27, 1815–1825 (2018). https://doi.org/10.1007/s11136-018-1843-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-018-1843-2